1. Home
  2. PRLD vs HIO Comparison

PRLD vs HIO Comparison

Compare PRLD & HIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

N/A

Current Price

$3.90

Market Cap

260.2M

Sector

Health Care

ML Signal

N/A

Logo Western Asset High Income Opportunity Fund Inc.

HIO

Western Asset High Income Opportunity Fund Inc.

N/A

Current Price

$3.27

Market Cap

311.9M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
PRLD
HIO
Founded
2016
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
260.2M
311.9M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
PRLD
HIO
Price
$3.90
$3.27
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $9.20
N/A
AVG Volume (30 Days)
370.4K
★ 722.2K
Earning Date
11-11-2026
01-01-0001
Dividend Yield
N/A
★ 10.33%
EPS Growth
★ 23.21
N/A
EPS
N/A
★ N/A
Revenue
★ $12,140,000.00
N/A
Revenue This Year
$258.83
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 73.43
N/A
52 Week Low
$1.17
$3.18
52 Week High
$6.83
$3.84

Technical Indicators

Market Signals
Indicator
PRLD
HIO
Relative Strength Index (RSI) 49.87 46.92
Support Level $3.38 $3.21
Resistance Level $4.07 $3.33
Average True Range (ATR) 0.29 0.04
MACD 0.11 0.01
Stochastic Oscillator 68.22 56.67

Price Performance

Historical Comparison
PRLD
HIO

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.

About HIO Western Asset High Income Opportunity Fund Inc.

Western Asset High Income Oppor Fd Inc is a diversified closed-end management investment company. The company's primary objective is to seek high current income and the secondary objective is capital appreciation. It invests a majority of its net assets in high-yield corporate debt securities and the rest in common stock equivalents, including options, warrants, and rights. The company invests in securities of companies from various sectors such as energy, technology, utilities, industrials, communications, finance, and capital goods among others.

Share on Social Networks: